Душинская Мария

Maria Dusinska, RNDr. PhD., DSc: Over 35 years of experience in the field of environment and health, genetic toxicology, molecular epidemiology, biomonitoring and biomarkers, DNA damage and repair, mutagenicity/carcinogenicity, nanotoxicology, hazard and risk assessment, in vitro/in vivo studies, molecular and cellular toxicology. In 2024 she received Fritz Sobels Award (EEMGS) and State Award Ludovit Stur Order II. from the President of Slovak Republic and in 2017 Babak Medal from Czecho-Slovak Biological Society.

Between 1995-2006, she was Head of Molecular Toxicology Laboratory and Head of Department of Experimental and Applied Genetics at Slovak Medical University (SMU), Bratislava, Director of Molecular Medicine Institute (2005-2006). From 2006 she works at NILU where she is Director of Health Effects Laboratory. The laboratories leaded by Dr Dusinska have been certified for OECD GLP (1998-2006 and from 2013-present). She was teaching ‘DNA instability and human health’ at Comenius University Bratislava (1997-2020) and between 2004 to 2016 she was teaching at Oslo University subject ‘Food toxicology’. Between years 2000-2005 she was in the OECD working group for biotechnology and regulatory toxicology, and recently she is in OECD expert group for genetic toxicology and nanotoxicology. In 2005-2006 she was national expert working at EC DG RTD Health at Brussels, Belgium responsible for alternative toxicity tests. In 2008 she was a member of EC FP7 Advisory Group for Environment (including climate change). From 2013-2023 she was a member of the Scientific Committee on Consumer Safety (SCCS) set up by Commission Decision 2008/721/EC, and from 2020 she is member of crosscutting working group on genotoxicity in EFSA. She is editor of international journals: Mutagenesis (until 2015), Basic & Clinical Pharmacogy & Toxicology, Environmental Research (until 2017), Nanomaterials, Food and Chemical Toxicology (until 2023), Frontiers in Toxicology and Mutation Research. She was guest editor for special issue (SI) in journals: Nanotoxicology (2015), Environmental Molecular Mutagenesis (2015), Mutagenesis (2017), SI in Mutation Research (2019, 2022), Nanomaterials (2020), Frontiers in Toxicology section Nanotoxicology (2022). Publications: more than 350 publications in peer reviewed journals and book chapters and over over 21800 citations, h-score 74 (Google Scholar). She coordinated H2020 NMBP13 RiskGONE (2019-2023, https://riskgone.wp.nilu.no/ on Science-Based Risk Governance of Nanotechnology), coordinated FP7 project NanoTEST (2008-2012; http://www.nanotest-fp7.eu/) focused on development of testing strategies for nanomaterials. In 2000-2006 she Coordinated FP5 EC project Centre of Excellence in Environmental Health HEAR NAS. She was partner in numerous of FP5, FP6, FP7, H2020 and and HORIZONE Europe projects such as FIBRETOX, ESCODD, INTARESE, HENVINET, HEIMTSA, COMICS, NewGeneris, NanoImpactNet; coordinator of FP7 Marie Curie project NanOmega; WP leader in Marie Curie Initial Training Network NanoTOES (http://www.nanotoes.eu/; both projects focused on toxicity of nanosilver); partner in QNANO (http://www.qualitynano.eu/; task leader for genotoxicity) and NanoREG (task leader for intelligent testing strategy and high throughput methods; http://www.nanoreg.eu/) and task leader for high throughput method s in the Horizon 2020 project NANoREG2. She is involved in several Horizon Europe projects (ANALYST, Proplanet, BLUECOAT, GREEN, etc.) and participated in several other H2020 projects (NanoSolveIT, HISENTS, NANoREG2, SaByDOMA, etc.). She coordinated national project NorNanoREG in NanoSafety and is involved in NFR project INTER and NanoBioReal (focussed on new 3D models), COST Action Human Comet and leader of WG on cells. She participated in the Euronanomed II and III project GEMNS, CELLUX, TEPCAN, INNOCENT and others, wis WP leader in H2020 NanoSolveIT, SaByDOMA and the TWINNIG projects VISION and TWINALT, participated in several EEA bilateral grants, such as in Norwegian—Czech EEA project on eye tissue engineering EYFORTX. She is involved in several OECD projects and is in IATA and genotoxicity WGs. Since 1996 she is involved in various genotoxicity networks, particularly in relation to the comet assay, and since 2005 she is actively involved in an international network on nanomaterial safety (NanoCluster). She is a member of the Standards Norway ISO Committee ISO/TC229 on nanotechnology (from 2008). Member of the ComNet steering committee, member of Norwegian SafeNano platform; National coordinator of NanoSafety representing Norway in FP7 NanoREG.

Education and training: Doctor of Science, DSc (Research professor - 2018), European Research Scientist (ERT, 2013). CSc. (relevant to PhD, 1991), Rerum Naturalis Doctor (RNDr., 1980), MsC. (1980), all in Comenius University: trained in biology, genetics, genetic toxicology, mutagenesis and carcinogenesis, biomonitoring, molecular epidemiology.